Does PEGFILGRASTIM-CBQV Cause Neoplasm malignant? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neoplasm malignant have been filed in association with PEGFILGRASTIM-CBQV. This represents 0.7% of all adverse event reports for PEGFILGRASTIM-CBQV.
5
Reports of Neoplasm malignant with PEGFILGRASTIM-CBQV
0.7%
of all PEGFILGRASTIM-CBQV reports
5
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm malignant From PEGFILGRASTIM-CBQV?
Of the 5 reports, 5 (100.0%) resulted in death.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGFILGRASTIM-CBQV. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PEGFILGRASTIM-CBQV Cause?
Device malfunction (356)
No adverse event (265)
Death (76)
Product dose omission issue (61)
Product label confusion (36)
Accidental exposure to product (29)
Neutrophil count decreased (18)
Bone pain (17)
Device failure (16)
Product packaging confusion (16)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which PEGFILGRASTIM-CBQV Alternatives Have Lower Neoplasm malignant Risk?
PEGFILGRASTIM-CBQV vs PEGFILGRASTIM-JMDB
PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA
PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA-2A
PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B
PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B OR PEGINTERFERON BETA-1A OR PEGINTERFERON LAMBDA-1A